Involvement of a gut-retina axis in protection against dietary glycemia-induced age-related macular degeneration

Proceedings of the National Academy of Sciences of the United States of America

Volumn 114, Issue 22, 2017, Pages E4472-E4481

  Rowan, Sheldon ^a   Jiang, Shuhong ^a   Korem, Tal ^b   Szymanski, Jedrzej ^b   Chang, Min Lee ^a   Szelog, Jason ^a   Cassalman, Christa ^c   Dasuri, Kalavathi ^a   McGuire, Christina ^c   Nagai, Ryoji ^d   Du, Xue Liang ^e   Brownlee, Michael ^e   Rabbani, Naila ^f   Thornalley, Paul J ^f   Baleja, James D ^c   Deik, Amy A ^g   Pierce, Kerry A ^g   Scott, Justin M ^g   Clish, Clary B ^g   Smith, Donald E ^a   Weinberger, Adina ^b   Avnit Sagi, Tali ^b   Lotan Pompan, Maya ^b   Segal, Eran ^b   Taylor, Allen ^a   more..

^a TUFTS UNIVERSITY   (United States)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d TOKAI UNIVERSITY   (Japan)

^e ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^f UNIVERSITY OF WARWICK   (United Kingdom)

^g MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Advanced glycation end product; Age related macular degeneration; Glycemic index; Gut microbiome; Metabolomics

Indexed keywords

4 HYDROXYPHENYLACETIC ACID; ADVANCED GLYCATION END PRODUCT; CARNITINE; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; HIPPURIC ACID; INDICAN; POLYUNSATURATED FATTY ACID; PROTEIN DERIVATIVE; SEROTONIN; TRIMETHYLAMINE; TRYPTOPHAN; TYROSINE;

AGE RELATED MACULAR DEGENERATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTEROIDALES; CALORIC INTAKE; CARBOHYDRATE DIET; CLINICAL FEATURE; CLOSTRIDIALES; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; GLUCOSE BLOOD LEVEL; GLUCOSE INTAKE; HYPOPIGMENTATION; INTESTINE; INTESTINE FLORA; LIPID PEROXIDATION; LIPOFUSCINOSIS; MALE; METABOLOMICS; MOUSE; NONHUMAN; PHOTORECEPTOR; PHOTORECEPTOR CELL; PLASMA; PRIORITY JOURNAL; RETINA; RETINA GYRATE ATROPHY; RETINAL PIGMENT EPITHELIUM; TIGHT JUNCTION; URINALYSIS; ANIMAL; GLYCEMIC INDEX; MACULAR DEGENERATION; METABOLISM; METABOLOME; PHYSIOLOGY;

ANIMALS; BLOOD GLUCOSE; GASTROINTESTINAL MICROBIOME; GLYCATION END PRODUCTS, ADVANCED; GLYCEMIC INDEX; MACULAR DEGENERATION; METABOLOME; METABOLOMICS; MICE; RETINA;

EID: 85019999414     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1702302114     Document Type: Article

References (97)

1. Wong WL, et al. (2014) Global prevalence of age-related macular degeneration anddisease burden projection for 2020 and 2040: A systematic review and meta-analysis.Lancet Glob Health 2:e106-e116.
2. AMD Alliance International (2010) The Global Economic Cost of Visual Impairment, March 2010. Available at http://www.icoph.org/resources/146/The-Global-Economic-Cost-of-Visual-Impairment.html. Accessed April 28, 2017.
3. Lambert NG, et al. (2016) Risk factors and biomarkers of age-related macular degeneration.Prog Retin Eye Res 54:64-102.
4. Weikel KA, Chiu CJ, Taylor A (2012) Nutritional modulation of age-related maculardegeneration. Mol Aspects Med 33:318-375.
5. Age-Related Eye Disease Study 2 Research Group (2013) Lutein + zeaxanthin andomega-3 fatty acids for age-related macular degeneration: The Age-Related EyeDisease Study 2 (AREDS2) randomized clinical trial. JAMA 309:2005-2015.
6. Seddon JM (2013) Genetic and environmental underpinnings to age-related oculardiseases. Invest Ophthalmol Vis Sci 54:ORSF, 28-30.
7. Chiu CJ, Taylor A (2011) Dietary hyperglycemia, glycemic index and metabolic retinaldiseases. Prog Retin Eye Res 30:18-53.
8. Kaushik S, et al. (2008) Dietary glycemic index and the risk of age-related maculardegeneration. Am J Clin Nutr 88:1104-1110.
9. Chiu CJ, Milton RC, Gensler G, Taylor A (2007) Association between dietary glycemicindex and age-related macular degeneration in nondiabetic participants in the Age-Related Eye Disease Study. Am J Clin Nutr 86:180-188.
10. Weikel KA, et al. (2012) Natural history of age-related retinal lesions that precedeAMD in mice fed high or low glycemic index diets. Invest Ophthalmol Vis Sci 53:622-632.
11. Uchiki T, et al. (2012) Glycation-altered proteolysis as a pathobiologic mechanism thatlinks dietary glycemic index, aging, age-related disease (in nondiabetics). AgingCell 11:1-13.
12. Loske C, et al. (1998) Cytotoxicity of advanced glycation endproducts is mediated byoxidative stress. J Neural Transm (Vienna) 105:1005-1015.
13. Vlassara H, Striker GE (2013) Advanced glycation endproducts in diabetes and diabeticcomplications. Endocrinol Metab Clin North Am 42:697-719.
14. Pennesi ME, Neuringer M, Courtney RJ (2012) Animal models of age related maculardegeneration. Mol Aspects Med 33:487-509.
15. Toomey CB, Kelly U, Saban DR, Bowes Rickman C (2015) Regulation of age-relatedmacular degeneration-like pathology by complement factor H. Proc Natl Acad Sci USA112:E3040-E3049.
16. Woodell A, et al. (2016) A targeted inhibitor of the alternative complement pathwayaccelerates recovery from smoke-induced ocular injury. Invest Ophthalmol Vis Sci 57:1728-1737.
17. Espinosa-Heidmann DG, et al. (2006) Cigarette smoke-related oxidants and the developmentof sub-RPE deposits in an experimental animal model of dry AMD. InvestOphthalmol Vis Sci 47:729-737.
18. Handa JT (2012) How does the macula protect itself from oxidative stress? MolAspects Med 33:418-435.
19. Scribner KB, Pawlak DB, Aubin CM, Majzoub JA, Ludwig DS (2008) Long-term effectsof dietary glycemic index on adiposity, energy metabolism, physical activity inmice. Am J Physiol Endocrinol Metab 295:E1126-E1131.
20. Nankervis SA, Mitchell JM, Charchar FJ, McGlynn MA, Lewandowski PA (2013) Consumptionof a low glycaemic index diet in late life extends lifespan of Balb/c mice withdifferential effects on DNA damage. Longev Healthspan 2:4.
21. Leiter EH (2009) Selecting the "right" mouse model for metabolic syndrome and type2 diabetes research. Methods Mol Biol 560:1-17.
22. King AJ (2012) The use of animal models in diabetes research. Br J Pharmacol 166:877-894.
23. LaVail MM, Gorrin GM, Repaci MA, Yasumura D (1987) Light-induced retinal degenerationin albino mice and rats: Strain and species differences. Prog Clin Biol Res247:439-454.
24. Rowan S, et al. (2014) Cfh genotype interacts with dietary glycemic index to modulateage-related macular degeneration-like features in mice. Invest Ophthalmol Vis Sci 55:492-501.
25. Samuel MA, et al. (2014) LKB1 and AMPK regulate synaptic remodeling in old age.Nat Neurosci 17:1190-1197.
26. Zanzottera EC, et al. (2015) The Project MACULA retinal pigment epithelium gradingsystem for histology and optical coherence tomography in age-related macular degeneration.Invest Ophthalmol Vis Sci 56:3253-3268.
27. Sarks S, Cherepanoff S, Killingsworth M, Sarks J (2007) Relationship of basal laminardeposit and membranous debris to the clinical presentation of early age-relatedmacular degeneration. Invest Ophthalmol Vis Sci 48:968-977.
28. Marmorstein LY, et al. (2002) Aberrant accumulation of EFEMP1 underlies drusenformation in Malattia Leventinese and age-related macular degeneration. Proc NatlAcad Sci USA 99:13067-13072.
29. Ferrington DA, Sinha D, Kaarniranta K (2016) Defects in retinal pigment epithelial cellproteolysis and the pathology associated with age-related macular degeneration.Prog Retin Eye Res 51:69-89.
30. Rabbani N, Thornalley PJ (2015) Dicarbonyl stress in cell and tissue dysfunction contributingto ageing and disease. Biochem Biophys Res Commun 458:221-226.
31. Glenn JV, Stitt AW (2009) The role of advanced glycation end products in retinalageing and disease. Biochim Biophys Acta 1790:1109-1116.
32. Ni J, et al.; Clinical Genomic and Proteomic AMD Study Group (2009) Plasma proteinpentosidine and carboxymethyllysine, biomarkers for age-related macular degeneration.Mol Cell Proteomics 8:1921-1933.
33. Berner AK, et al. (2012) Protection against methylglyoxal-derived AGEs by regulationof glyoxalase 1 prevents retinal neuroglial and vasodegenerative pathology.Diabetologia 55:845-854.
34. Wang H, et al.; Clinical Genomic and Proteomic AMD Study Group (2014) Detectionand biological activities of carboxyethylpyrrole ethanolamine phospholipids (CEPEPs).Chem Res Toxicol 27:2015-2022.
35. De La Paz M, Anderson RE (1992) Region and age-dependent variation in susceptibilityof the human retina to lipid peroxidation. Invest Ophthalmol Vis Sci 33:3497-3499.
36. Fliesler SJ, Anderson RE (1983) Chemistry and metabolism of lipids in the vertebrateretina. Prog Lipid Res 22:79-131.
37. Hollyfield JG, et al. (2008) Oxidative damage-induced inflammation initiates agerelatedmacular degeneration. Nat Med 14:194-198.
38. Gu X, et al. (2003) Carboxyethylpyrrole protein adducts and autoantibodies, biomarkersfor age-related macular degeneration. J Biol Chem 278:42027-42035.
39. Wikoff WR, et al. (2009) Metabolomics analysis reveals large effects of gut microfloraon mammalian blood metabolites. Proc Natl Acad Sci USA 106:3698-3703.
40. Zhang LS, Davies SS (2016) Microbial metabolism of dietary components to bioactivemetabolites: Opportunities for new therapeutic interventions. Genome Med 8:46.
41. Collier RJ, et al. (2011) Agonists at the serotonin receptor (5-HT(1A)) protect the retinafrom severe photo-oxidative stress. Invest Ophthalmol Vis Sci 52:2118-2126.
42. Tullis BE, et al. (2015) Sarpogrelate, a 5-HT2A Receptor Antagonist, Protects theRetina From Light-Induced Retinopathy. Invest Ophthalmol Vis Sci 56:4560-4569.
43. Biswal MR, et al. (2015) Systemic treatment with a 5HT1a agonist induces anti-oxidantprotection and preserves the retina from mitochondrial oxidative stress. Exp Eye Res140:94-105.
44. Renganathan K, et al. (2013) CEP biomarkers as potential tools for monitoring therapeutics.PLoS One 8:e76325.
45. Yatsunenko T, et al. (2012) Human gut microbiome viewed across age and geography.Nature 486:222-227.
46. Langille MG, et al. (2014) Microbial shifts in the aging mouse gut. Microbiome 2:50.
47. Clemente JC, Ursell LK, Parfrey LW, Knight R (2012) The impact of the gut microbiotaon human health: An integrative view. Cell 148:1258-1270.
48. Yano JM, et al. (2015) Indigenous bacteria from the gut microbiota regulate hostserotonin biosynthesis. Cell 161:264-276.
49. Sarkar S, et al. (2014) Neuroprotective effect of the chemical chaperone, trehalose ina chronic MPTP-induced Parkinson's disease mouse model. Neurotoxicology 44:250-262.
50. Emanuele E (2014) Can trehalose prevent neurodegeneration? Insights from experimentalstudies. Curr Drug Targets 15:551-557.
51. Kurihara T, et al. (2016) Hypoxia-induced metabolic stress in retinal pigment epithelialcells is sufficient to induce photoreceptor degeneration. eLife 5:5.
52. Pikuleva IA, Curcio CA (2014) Cholesterol in the retina: The best is yet to come. ProgRetin Eye Res 41:64-89.
53. Barber AJ, et al. (1998) Neural apoptosis in the retina during experimental and humandiabetes. Early onset and effect of insulin. J Clin Invest 102:783-791.
54. Aizu Y, Oyanagi K, Hu J, Nakagawa H (2002) Degeneration of retinal neuronal processesand pigment epithelium in the early stage of the streptozotocin-diabetic rats.Neuropathology 22:161-170.
55. Martin PM, Roon P, Van Ells TK, Ganapathy V, Smith SB (2004) Death of retinalneurons in streptozotocin-induced diabetic mice. Invest Ophthalmol Vis Sci 45:3330-3336.
56. Boynton GE, et al. (2015) Multimodal characterization of proliferative diabetic retinopathyreveals alterations in outer retinal function and structure. Ophthalmology122:957-967.
57. Badr GA, Tang J, Ismail-Beigi F, Kern TS (2000) Diabetes downregulates GLUT1 expression inthe retina and itsmicrovessels but not in the cerebral cortex or its microvessels. Diabetes 49:1016-1021.
58. Sohn EJ, Kim YS, Kim CS, Lee YM, Kim JS (2009) KIOM-79 prevents apoptotic celldeath and AGEs accumulation in retinas of diabetic db/db mice. J Ethnopharmacol121:171-174.
59. Genuth S, et al.; DCCT/EDIC Research Group (2015) Skin advanced glycation endproducts glucosepane and methylglyoxal hydroimidazolone are independently associatedwith long-term microvascular complication progression of type 1 diabetes.Diabetes 64:266-278.
60. Shang F, Taylor A (2012) Roles for the ubiquitin-proteasome pathway in proteinquality control and signaling in the retina: Implications in the pathogenesis of agerelatedmacular degeneration. Mol Aspects Med 33:446-466.
61. Diaz Heijtz R, et al. (2011) Normal gut microbiota modulates brain development andbehavior. Proc Natl Acad Sci USA 108:3047-3052.
62. Besharse JC, Spratt G, Reif-Lehrer L (1988) Effects of kynurenate and other excitatoryamino acid antagonists as blockers of light-A nd kainate-induced retinal rod photoreceptordisc shedding. J Comp Neurol 274:295-303.
63. Mackenzie AE, Milligan G (2015) The emerging pharmacology and function ofGPR35 in the nervous system. Neuropharmacol 113:661-671.
64. Andriessen EM, et al. (2016) Gut microbiota influences pathological angiogenesis inobesity-driven choroidal neovascularization. EMBO Mol Med 8:1366-1379.
65. Zinkernagel MS, et al. (2017) Association of the intestinal microbiome with the developmentof neovascular age-related macular degeneration. Sci Rep 7:40826.
66. Bylesjö M, Eriksson D, Kusano M, Moritz T, Trygg J (2007) Data integration in plantbiology: The O2PLS method for combined modeling of transcript and metabolitedata. Plant J 52:1181-1191.
67. Mevik B, Wehrens R (2007) The pls package: Principal component and partial leastsquares regression in R. J Stat Softw 18:1-24.
68. Bylesjo M, et al. (2006) OPLS discriminant analysis: Combining the strengths of PLS-DAand SIMCA classification. J Chemometr 20:341-351.
69. Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: A practical andpowerful approach to multiple testing. J R Stat Soc B 95:289-300.
70. Rabbani N, Shaheen F, Anwar A, Masania J, Thornalley PJ (2014) Assay ofmethylglyoxal-derived protein and nucleotide AGEs. Biochem Soc Trans 42:511-517.
71. Townsend MK, et al. (2013) Reproducibility of metabolomic profiles among men andwomen in 2 large cohort studies. Clin Chem 59:1657-1667.
72. Weljie AM, Newton J, Mercier P, Carlson E, Slupsky CM (2006) Targeted profiling:Quantitative analysis of 1H NMR metabolomics data. Anal Chem 78:4430-4442.
73. Suez J, et al. (2014) Artificial sweeteners induce glucose intolerance by altering thegut microbiota. Nature 514:181-186.
74. Zeevi D, et al. (2015) Personalized nutrition by prediction of glycemic responses. Cell163:1079-1094.
75. Shannon P, et al. (2003) Cytoscape: A software environment for integrated models ofbiomolecular interaction networks. Genome Res 13:2498-2504.
76. Troyanskaya O, et al. (2001) Missing value estimation methods for DNA microarrays.Bioinformatics 17:520-525.
77. Wishart DS, et al. (2009) HMDB: A knowledgebase for the human metabolome.Nucleic Acids Res 37:D603-D610.
78. Bouatra S, et al. (2013) The human urine metabolome. PLoS One 8:e73076.
79. Jung JY, et al. (2012) 1H NMR-based metabolite profiling of diet-induced obesity in amouse mode. BMB Rep 45:419-424.
80. Frolkis A, et al. (2010) SMPDB: The small molecule pathway database. Nucleic AcidsRes 38:D480-D487.
81. Bolger AM, Lohse M, Usadel B (2014) Trimmomatic: A flexible trimmer for Illuminasequence data. Bioinformatics 30:2114-2120.
82. Zhang J, Kobert K, Flouri T, Stamatakis A (2014) PEAR: A fast and accurate IlluminaPaired-End reAd mergeR. Bioinformatics 30:614-620.
83. Edgar RC (2013) UPARSE: Highly accurate OTU sequences from microbial ampliconreads. Nat Methods 10:996-998.
84. Caporaso JG, et al. (2010) QIIME allows analysis of high-throughput community sequencingdata. Nat Methods 7:335-336.
85. Langille MG, et al. (2013) Predictive functional profiling of microbial communitiesusing 16S rRNA marker gene sequences. Nat Biotechnol 31:814-821.
86. DeSantis TZ, et al. (2006) Greengenes, a chimera-checked 16S rRNA gene databaseand workbench compatible with ARB. Appl Environ Microbiol 72:5069-5072.
87. Nagai R, et al. (2008) Immunochemical detection of Nepsilon-(carboxyethyl)lysineusing a specific antibody. J Immunol Methods 332:112-120.
88. Matsumoto K, Fujiwara Y, Nagai R, Yoshida M (2009) Immunohistochemical detectionof advanced glycation end products in human bladder with specific monoclonal antibody.Int J Urol 16:402-405, discussion 405-406.
89. Nishikawa T, et al. (2000) Normalizing mitochondrial superoxide production blocksthree pathways of hyperglycaemic damage. Nature 404:787-790.
90. Russell WR, et al. (2013) Major phenylpropanoid-derived metabolites in the humangut can arise from microbial fermentation of protein. Mol Nutr Food Res 57:523-535.
91. Tang WH, et al. (2013) Intestinal microbial metabolism of phosphatidylcholine andcardiovascular risk. N Engl J Med 368:1575-1584.
92. Koeth RA, et al. (2013) Intestinal microbiota metabolism of L-carnitine, a nutrient inred meat, promotes atherosclerosis. Nat Med 19:576-585.
93. al-Waiz M, Mikov M, Mitchell SC, Smith RL (1992) The exogenous origin of trimethylaminein the mouse. Metabolism 41:135-136.
94. Clarke G, et al. (2013) The microbiome-gut-brain axis during early life regulates thehippocampal serotonergic system in a sex-dependent manner. Mol Psychiatry 18:666-673.
95. Yap IK, et al. (2008) Metabonomic and microbiological analysis of the dynamic effectof vancomycin-induced gut microbiota modification in the mouse. J Proteome Res 7:3718-3728.
96. Yuan JP, Wang JH, Liu X (2007) Metabolism of dietary soy isoflavones to equol byhuman intestinal microflora-implications for health. Mol Nutr Food Res 51:765-781.
97. Sayin SI, et al. (2013) Gut microbiota regulates bile acid metabolism by reducing thelevels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab17:225-235.